Menu Search
Equities

Xtant Medical Holdings Inc

XMS:BER

Xtant Medical Holdings Inc

Actions
  • Price (EUR)0.394
  • Today's Change-0.004 / -1.01%
  • Shares traded--
  • 1 Year change-64.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Xtant Medical Holdings Inc grew revenues 57.50% from 57.97m to 91.30m while net income improved from a loss of 8.49m to a gain of 660.00k.
Gross margin61.61%
Net profit margin-3.00%
Operating margin-1.72%
Return on assets-4.15%
Return on equity-8.78%
Return on investment-5.77%
More ▼

Cash flow in USDView more

In 2023, cash reserves at Xtant Medical Holdings Inc fell by 14.58m. Cash Flow from Financing totalled 19.69m or 21.57% of revenues. In addition the company used 9.52m for operations while cash used for investing totalled 24.78m.
Cash flow per share0.0044
Price/Cash flow per share127.43
Book value per share0.3454
Tangible book value per share0.2186
More ▼

Balance sheet in USDView more

Xtant Medical Holdings Inc has a Debt to Total Capital ratio of 42.90%, a lower figure than the previous year's 53.46%.
Current ratio2.44
Quick ratio1.01
Total debt/total equity0.7514
Total debt/total capital0.429
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.